BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31311500)

  • 1. Adaptive propensity score procedure improves matching in prospective observational trials.
    Weber D; Uhlmann L; Schönenberger S; Kieser M
    BMC Med Res Methodol; 2019 Jul; 19(1):150. PubMed ID: 31311500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving sample size recalculation in adaptive clinical trials by resampling.
    Herrmann C; Kluge C; Pilz M; Kieser M; Rauch G
    Pharm Stat; 2021 Nov; 20(6):1035-1050. PubMed ID: 33792167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data.
    Harden M; Friede T
    Biom J; 2020 Sep; 62(5):1284-1299. PubMed ID: 32128868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
    Sawamoto R; Oba K; Matsuyama Y
    Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity score matching for estimating a marginal hazard ratio.
    Wang T; Zhao H; Yang S; Tang S; Cui Z; Li L; Faries DE
    Stat Med; 2024 Jun; 43(14):2783-2810. PubMed ID: 38705726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension of a conditional performance score for sample size recalculation rules to the setting of binary endpoints.
    Bokelmann B; Rauch G; Meis J; Kieser M; Herrmann C
    BMC Med Res Methodol; 2024 Jan; 24(1):15. PubMed ID: 38243169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five Steps to Successfully Implement and Evaluate Propensity Score Matching in Clinical Research Studies.
    Staffa SJ; Zurakowski D
    Anesth Analg; 2018 Oct; 127(4):1066-1073. PubMed ID: 29324498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size calculation and blinded recalculation for analysis of covariance models with multiple random covariates.
    Zimmermann G; Kieser M; Bathke AC
    J Biopharm Stat; 2020; 30(1):143-159. PubMed ID: 31327284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score matching and subclassification in observational studies with multi-level treatments.
    Yang S; Imbens GW; Cui Z; Faries DE; Kadziola Z
    Biometrics; 2016 Dec; 72(4):1055-1065. PubMed ID: 26991040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls.
    Yuan J; Liu J; Zhu R; Lu Y; Palm U
    J Biopharm Stat; 2019; 29(3):558-573. PubMed ID: 30612514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of bootstrapping when using propensity-score matching without replacement: a simulation study.
    Austin PC; Small DS
    Stat Med; 2014 Oct; 33(24):4306-19. PubMed ID: 25087884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why caution is recommended with post-hoc individual patient matching for estimation of treatment effect in parallel-group randomized controlled trials: the case of acute stroke trials.
    Jafari N; Hearne J; Churilov L
    Stat Med; 2013 Nov; 32(25):4467-81. PubMed ID: 23761106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
    Herrmann C; Pilz M; Kieser M; Rauch G
    Stat Med; 2020 Jul; 39(15):2067-2100. PubMed ID: 32249968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample Size Estimation in Clinical Research: From Randomized Controlled Trials to Observational Studies.
    Wang X; Ji X
    Chest; 2020 Jul; 158(1S):S12-S20. PubMed ID: 32658647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size recalculation based on the prevalence in a randomized test-treatment study.
    Hot A; Benda N; Bossuyt PM; Gerke O; Vach W; Zapf A
    BMC Med Res Methodol; 2022 Jul; 22(1):205. PubMed ID: 35879675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoothing Corrections for Improving Sample Size Recalculation Rules in Adaptive Group Sequential Study Designs.
    Herrmann C; Rauch G
    Methods Inf Med; 2021 May; 60(1-02):1-8. PubMed ID: 33648007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD; Peduzzi PN
    Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.